Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

BioMarin Pharmaceutical Inc. - Common Stock (NQ:BMRN)

58.67 -1.35 (-2.25%)
Streaming Delayed Price Updated: 10:20 AM EDT, Apr 16, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 94,260
Open 59.66
Bid (Size) 58.66 (1)
Ask (Size) 58.86 (3)
Prev. Close 60.02
Today's Range 58.64 - 60.46
52wk Range 52.93 - 94.85
Shares Outstanding 183,352,255
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Unpacking Q4 Earnings: AbbVie (NYSE:ABBV) In The Context Of Other Therapeutics Stocks
The end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Let’s take a look at how therapeutics stocks fared in Q4, starting with AbbVie... 
Via StockStory
Topics Artificial Intelligence
Exposures Artificial Intelligence
6 Stocks With Clear Price Dislocations That I Purchased During Wall Street's Historic Volatility
Though the stock market is still historically pricey, a few phenomenal bargains have cropped up. 
Via The Motley Fool
Topics Government Stocks World Trade
Exposures COVID-19 Political Tariff

Performance

YTD
-11.8%
-11.8%
1 Month
-18.0%
-18.0%
3 Month
-8.1%
-8.1%
6 Month
-16.7%
-16.7%
1 Year
-35.9%
-35.9%

More News

Read More
Spotting Winners: United Therapeutics (NASDAQ:UTHR) And Therapeutics Stocks In Q4
Via StockStory
Topics Artificial Intelligence
Exposures Artificial Intelligence
Demystifying Biomarin Pharmaceutical: Insights From 8 Analyst Reviews
Via Benzinga
Q4 Earnings Outperformers: Amgen (NASDAQ:AMGN) And The Rest Of The Therapeutics Stocks
Via StockStory
Topics Artificial Intelligence
Exposures Artificial Intelligence
BioMarin Seeks Label Expansion For Palynziq After Positive Phase 3 Results In Adolescent Patients
Via Benzinga
The Future of Healthcare: 10 Predictions For The Next Decade
Via MarketMinute
Topics Artificial Intelligence
Exposures Artificial Intelligence COVID-19
5 Historically Cheap Growth Stocks to Buy With Confidence in the Wake of the Nasdaq Correction
Via The Motley Fool
2 Reasons to Like BMRN (and 1 Not So Much)
Via StockStory
Q4 Rundown: Moderna (NASDAQ:MRNA) Vs Other Therapeutics Stocks
Via StockStory
Topics Artificial Intelligence
Exposures Artificial Intelligence
Q4 Earnings Review: Therapeutics Stocks Led by BioMarin Pharmaceutical (NASDAQ:BMRN)
Via StockStory
Topics Artificial Intelligence
Exposures Artificial Intelligence
Q4 Rundown: Biogen (NASDAQ:BIIB) Vs Other Therapeutics Stocks
Via StockStory
Topics Artificial Intelligence
Exposures Artificial Intelligence
A Look Back at Therapeutics Stocks’ Q4 Earnings: Vertex Pharmaceuticals (NASDAQ:VRTX) Vs The Rest Of The Pack
Via StockStory
Topics Artificial Intelligence
Exposures Artificial Intelligence
1 Healthcare Stock to Target This Week and 2 to Turn Down
Via StockStory
Topics Stocks
Exposures COVID-19 US Equities
Winners And Losers Of Q4: Myriad Genetics (NASDAQ:MYGN) Vs The Rest Of The Therapeutics Stocks
Via StockStory
Topics Artificial Intelligence
Exposures Artificial Intelligence
BIOMARIN PHARMACEUTICAL INC (NASDAQ:BMRN) is a prime example of a stock that offers more than what meets the eye in terms of fundamentals.
Via Chartmill
Spotting Winners: Sarepta Therapeutics (NASDAQ:SRPT) And Therapeutics Stocks In Q4
Via StockStory
Topics Artificial Intelligence
Exposures Artificial Intelligence
Sarepta Therapeutics (SRPT) To Report Earnings Tomorrow: Here Is What To Expect
Via StockStory
What To Expect From United Therapeutics’s (UTHR) Q4 Earnings
Via StockStory
What To Expect From Myriad Genetics’s (MYGN) Q4 Earnings
Via StockStory
Why BioMarin Pharmaceutical Stock Zoomed Almost 5% Higher Today
Via The Motley Fool
Why BioMarin Pharmaceutical (BMRN) Stock Is Trading Up Today
Via StockStory
Why Is BioMarin Stock Trading Higher On Thursday?
Via Benzinga
BioMarin: EPS Surges Past Expectations
Via The Motley Fool
BioMarin Pharmaceutical (NASDAQ:BMRN) Reports Bullish Q4, Stock Soars
Via StockStory

Frequently Asked Questions

Is BioMarin Pharmaceutical Inc. - Common Stock publicly traded?
Yes, BioMarin Pharmaceutical Inc. - Common Stock is publicly traded.
What exchange does BioMarin Pharmaceutical Inc. - Common Stock trade on?
BioMarin Pharmaceutical Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for BioMarin Pharmaceutical Inc. - Common Stock?
The ticker symbol for BioMarin Pharmaceutical Inc. - Common Stock is BMRN on the Nasdaq Stock Market
What is the current price of BioMarin Pharmaceutical Inc. - Common Stock?
The current price of BioMarin Pharmaceutical Inc. - Common Stock is 58.67
When was BioMarin Pharmaceutical Inc. - Common Stock last traded?
The last trade of BioMarin Pharmaceutical Inc. - Common Stock was at 04/16/25 10:20 AM ET
What is the market capitalization of BioMarin Pharmaceutical Inc. - Common Stock?
The market capitalization of BioMarin Pharmaceutical Inc. - Common Stock is 10.76B
How many shares of BioMarin Pharmaceutical Inc. - Common Stock are outstanding?
BioMarin Pharmaceutical Inc. - Common Stock has 11B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.